Bruce Greenberg - 15 Jul 2022 Form 4 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Role
Interim Chief Financial Officer
Signature
/s/ Bruce Greenberg
Issuer symbol
ALDX
Transactions as of
15 Jul 2022
Net transactions value
$0
Form type
4
Filing time
19 Jul 2022, 16:34:33 UTC
Previous filing
13 May 2022
Next filing
02 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALDX Common Stock Award $0 +126,087 +1614% $0.000000 133,900 15 Jul 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock underlying a time-based restricted stock unit award (RSU). The RSU vests ratably in equal annual installments over a four-year period beginning on July 15, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.

Remarks:

Interim Chief Financial Officer